Eliasson, Björn

2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.

Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,642

Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes

Rawshani, A., Rawshani, A., Franzén, S., Sattar, N., Eliasson, B., Svensson, A.-M., Zethelius, B., Miftaraj, M., McGuire, D. K., Rosengren, A., et al. (2018) · New England Journal of Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 1,475

Mortality and cardiovascular disease in type 1 and type 2 diabetes

Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., & Gudbjörnsdottir, S. (2017) · New England Journal of Medicine

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,389

Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study

Rawshani, A., Sattar, N., Franzén, S., Rawshani, A., Hattersley, A. T., Svensson, A.-M., Eliasson, B., & Gudbjörnsdottir, S. (2018) · The Lancet

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 802

Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks: Findings From the Swedish National Diabetes Registry

Sattar, N., Rawshani, A., Franzén, S., Rawshani, A., Svensson, A.-M., Rosengren, A., McGuire, D. K., Eliasson, B., & Gudbjörnsdottir, S. (2019) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 555

SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, Pennells, L., Kaptoge, S., Østergaard, H. B., Read, S. H., Carinci, F., Franch-Nadal, J., Petitjean, C., Taylor, O., Hageman, S. H. J., et al. (2023) · European Heart Journal

Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular Prevention

Cited by 329

Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register

Ekström, N., Schiöler, L., Svensson, A.-M., Eeg-Olofsson, K., Miao Jonasson, J., Zethelius, B., Cederholm, J., Eliasson, B., & Gudbjörnsdottir, S. (2012) · BMJ Open

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 221

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: A randomised, double-blind, placebo-controlled, phase 2 trial

von Herrath, M., Bain, S. C., Bode, B., Clausen, J. O., Coppieters, K., Gaysina, L., Gumprecht, J., Hansen, T. K., Mathieu, C., Morales, C., et al. (2021) · The Lancet Diabetes & Endocrinology

Diabetes and associated disordersPancreatic function and diabetes

Cited by 186

New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)

Eeg‐Olofsson, K., Cederholm, J., Nilsson, P. M., Zethelius, B., Svensson, A. ‐., Gudbjörnsdóttir, S., & Eliasson, B. (2010) · Journal of Internal Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 178

Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus

Rawshani, A., Rawshani, A., Sattar, N., Franzén, S., McGuire, D. K., Eliasson, B., Svensson, A.-M., Zethelius, B., Miftaraj, M., Rosengren, A., et al. (2019) · Circulation

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 177

Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study

Eliasson, B., Liakopoulos, V., Franzén, S., Näslund, I., Svensson, A.-M., Ottosson, J., & Gudbjörnsdottir, S. (2015) · The Lancet Diabetes & Endocrinology

Bariatric Surgery and OutcomesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 167

Glucagon‐like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study

Pasternak, B., Wintzell, V., Hviid, A., Eliasson, B., Gudbjörnsdottir, S., Jonasson, C., Hveem, K., Svanström, H., Melbye, M., & Ueda, P. (2024) · BMJ

Diabetes Treatment and ManagementThyroid Cancer Diagnosis and Treatment

Cited by 125

Effects of hyperglycemia on interdigestive gastrointestinal motility in humans

Björnsson, E. S., Urbanavicius, V., Eliasson, B., Attvall, S., Smith, U., & Abrahamsson, H. (1994) · Scandinavian Journal of Gastroenterology

Gastrointestinal motility and disordersGastroesophageal reflux and treatments

Cited by 117

Fracture risk after gastric bypass surgery: a retrospective cohort study

Axelsson, K. F., Werling, M., Eliasson, B., Szabo, E., Näslund, I., Wedel, H., Lundh, D., & Lorentzon, M. (2018) · Journal of Bone and Mineral Research

Bariatric Surgery and OutcomesBone health and osteoporosis research

Cited by 105

GLP-1 Receptor Agonist Use and Risk of Suicide Death

Ueda, P., Söderling, J., Wintzell, V., Svanström, H., Pazzagli, L., Eliasson, B., Melbye, M., Hviid, A., & Pasternak, B. (2024) · JAMA Internal Medicine

Diabetes Treatment and ManagementSuicide and Self-Harm Studies

Cited by 103

A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR): Cardiovascular disease risk prediction in Type 1 diabetes

Cederholm, J., Eeg-Olofsson, K., Eliasson, B., Zethelius, B., Gudbjörnsdottir, S., & Register, O. B. O. T. S. N. D. (2011) · Diabetic Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 90

Association between use of lipid-lowering therapy and cardiovascular diseases and death in individuals with type 1 diabetes

Hero, C., Rawshani, A., Svensson, A.-M., Franzén, S., Eliasson, B., Eeg-Olofsson, K., & Gudbjörnsdottir, S. (2016) · Diabetes Care

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 78

Potential Effects of Bariatric Surgery on the Incidence of Heart Failure and Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus and Obesity and on Mortality in Patients With Preexisting Heart Failure: A Nationwide, Matched, Observational Cohort Study

Höskuldsdóttir, G., Sattar, N., Miftaraj, M., Näslund, I., Ottosson, J., Franzén, S., Svensson, A., & Eliasson, B. (2021) · Journal of the American Heart Association

Bariatric Surgery and OutcomesHeart Failure Treatment and Management

Cited by 70

Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial

Eliasson, B., Gudbjörnsdottir, S., Cederholm, J., Liang, Y., Vercruysse, F., & Smith, U. (2007) · International Journal of Obesity

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 57

Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study

Engström, A., Wintzell, V., Melbye, M., Svanström, H., Eliasson, B., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Hviid, A., Ueda, P., et al. (2024) · Hepatology

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 54

Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study

Ueda, P., Wintzell, V., Melbye, M., Eliasson, B., Söderling, J., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Svanström, H., Hviid, A., et al. (2024) · Clinical Gastroenterology and Hepatology

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 34

Effects of nutrition education using a food-based approach, carbohydrate counting or routine care in type 1 diabetes: 12 months prospective randomized trial

Sterner Isaksson, S., Bensow Bacos, M., Eliasson, B., Thors Adolfsson, E., Rawshani, A., Lindblad, U., Jendle, J., Berglund, A., Lind, M., & Axelsen, M. (2021) · BMJ Open Diabetes Research & Care

Diabetes Management and EducationDiabetes Management and Research

Cited by 31

Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study

Ueda, P., Wintzell, V., Melbye, M., Eliasson, B., Svensson, A.-M., Franzén, S., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Svanström, H., et al. (2021) · Diabetologia

Cholangiocarcinoma and Gallbladder Cancer StudiesDiabetes Treatment and Management

Cited by 31

Mortality in patients with diabetes mellitus and Addison's disease: a nationwide, matched, observational cohort study

Chantzichristos, D., Persson, A., Eliasson, B., Miftaraj, M., Franzén, S., Bergthorsdottir, R., Gudbjörnsdottir, S., Svensson, A.-M., & Johannsson, G. (2017) · European Journal of Endocrinology

Adrenal Hormones and DisordersDiabetes Management and Research

Cited by 30